Trial Profile
Autonomic Phenotype Before and After Akt Inhibition: Akt Therapy for Melanoma Sub-study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alisertib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 09 Jun 2016 New trial record